1
Esmir Gunic, Jean Luc Girardet, Jean Michel Vernier, Martina E Tedder, David A Paisner: Compounds, compositions and methods of using same for modulating uric acid levels. Ardea Biosciences, Wilson Sonsini Goodrich & Rosati, May 8, 2012: US08173690 (10 worldwide citation)

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of making and using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.


2
Esmir Gunic, Jean Luc Girardet, David A Paisner: Compounds, compositions and methods of using same for modulating uric acid levels. Ardea Biosciences, Wilson Sonsini Goodrich & Rosati, June 5, 2012: US08193234 (8 worldwide citation)

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of making and using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.


3
GUNIC ESMIR: Compounds, compositions and methods of using same for modulating uric acid levels. ARDEA BIOSCIENCES, Wilson Sonsini Goodrich & Rosati, March 11, 2010: WO/2010/028190 (8 worldwide citation)

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of making and using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.


4
Esmir Gunic, Jean Luc Girardet, Jean Michel Vernier, Martina E Tedder, David A Paisner: Compounds, compositions and methods of using same for modulating uric acid levels. Ardea Biosciences, Wilson Sonsini Goodrich & Rosati, August 14, 2012: US08242154 (7 worldwide citation)

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of making and using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.


5
GUNIC ESMIR: Compounds, compositions and methods of using same for modulating uric acid levels. ARDEA BIOSCIENCES, Wilson Sonsini Goodrich & Rosati, March 11, 2010: WO/2010/028189 (4 worldwide citation)

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of making and using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.


6
Esmir Gunic, Jean Luc Girardet, Jean Michel Vernier, Martina E Tedder, David A Paisner: Compounds, compositions and methods of using same for modulating uric acid levels. Ardea Biosciences, Wilson Sonsini Goodrich & Rosati, January 21, 2014: US08633232 (3 worldwide citation)

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of making and using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.


7
Esmir Gunic, Jean Luc Girardet, David A Paisner: Compounds, compositions and methods of using same for modulating uric acid levels. Ardea Biosciences, Wilson Sonsini Goodrich & Rosati, January 1, 2013: US08344012 (2 worldwide citation)

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of making and using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.


8

9

10
Esmir Gunic, Jean Luc Girardet, David A Paisner: Compounds, compositions and methods of using same for modulating uric acid levels. Ardea Biosciences, Wilson Sonsini Goodrich & Rosati, March 4, 2010: US20100056542-A1

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of making and using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid